FDA Approves Priteliver for Refractory Herpes Infections
The US FDA has approved pritelivir for refractory herpes infections, giving dermatologists a new option for patients who fail standard antiviral therapy.
Topic
Antiviral Therapy
Topic
Topic
Topic
The US FDA has approved pritelivir for refractory herpes infections, giving dermatologists a new option for patients who fail standard antiviral therapy.